Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
40–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Signed informed consent
Age ≥ 40 years
Patients fulfilling criteria for COPD according to the Global initiative for chronic obstructive pulmonary disease (GOLD) stage I or higher
Smokers or ex-smokers of at least 10 pack-years
Patients suffering an AECOPD either:
1. Admitted to hospital due to AECOPD (severe exacerbation) or
2. Confirmed AECOPD at GP (general practitioner) setting (moderate exacerbation) Definition AECOPD: Increase in respiratory symptoms requiring treatment with oral corticosteroids, antibiotics or both.
You may not be if
Patients who have never smoked
Patients with active long-term respiratory disease (e.g. bronchial asthma, cystic fibrosis, severe bronchiectasis, malignancy, restrictive lung diseases etc.)
Exacerbation of COPD due to other causes such as pneumothorax and acute decompensated congestive heart failure
Difficulties in communication (cognitive deterioration, sensorial disability, language barriers)
Severe disease with poor vital prognosis (life length expectancy less than one year)
Clareo Health | Predictive Questionnaires for Risk of Acute COPD (Chronic Obstructive Pulmonary Disease) Exacerbations
